NCT06779929 Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Status COMPLETED Phase N/A
NCT06774079 Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients Status RECRUITING Phase PHASE4
NCT06759701 Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study Status RECRUITING Phase EARLY_PHASE1
NCT06751589 A Study of a Weight Loss Intervention in People With Endometrial Cancer Status RECRUITING Phase EARLY_PHASE1
NCT06737042 Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants Status NOT_YET_RECRUITING Phase PHASE2
NCT06732245 Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese Status NOT_YET_RECRUITING Phase PHASE2
NCT06727331 Study of Tirzepatide for Recovery and Alcohol Use Management Status RECRUITING Phase PHASE2
NCT06700538 A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus Status RECRUITING Phase PHASE1/PHASE2
NCT06662383 A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06657209 Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide Status RECRUITING Phase PHASE4
NCT06651177 Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder Status RECRUITING Phase PHASE2
NCT06643728 A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06635057 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan Status COMPLETED Phase PHASE4
NCT06630585 GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes Status RECRUITING Phase PHASE3
NCT06606821 The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease Status RECRUITING Phase PHASE4
NCT06603571 A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06588296 Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight Status COMPLETED Phase PHASE3
NCT06588283 Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE3